For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Macrogol compound - Constipation
PAD Profile : Macrogol compound - Constipation
Traffic Light Status
Status 1 of 2.
- Sachets (powder)
Status 2 of 2.
- Sachets (powder)
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Methylnaltrexone bromide
- Prucalopride
- Naloxegol
- Ispaghula husk
- Bisacodyl
- Docusate sodium
- Glycerol
- Senna
- Lactulose
- Phosphates (Rectal)
- Sterculia
- Co-danthrusate (Dantron/docusate sodium)
- Co-danthramer (Dantron/poloxamer 188)
- Sodium citrate (Rectal)
- Naldemedine
- Arachis oil
- Magnesium hydroxide
- Sodium picosulfate
Other Indications
- Faecal impaction (adults)
- Faecal impaction (children)
- Pre-operative bowel cleansing (adults)
- Pre-operative bowel cleansing (children)
Additional Documents
No additional documents returned.
Committee Recommendations
The Surrey Heartlands APC have adopted the CKS principles for the management of constipation in adults.
Management | Constipation | CKS | NICE
The CKS guidance covers the management of constipation in adults (including pregnant women and those who are breastfeeding), for short-duration and chronic constipation, and faecal loading and/or impaction.
Refer to the formulary for Traffic Light status / place in therapy of locally agreed treatment options.
GENERIC macrogol compound has been considered by the APC and has been assigned a GREEN traffic light status.
NOTE - the branded product, Movicol, was considered NON-FORMULARY at the APC in May 2017